Last update:
Oncology news
How chemotherapy can backfire: An immune shift tied to tumor resistance and poorer outcomes
Chemotherapy can be life-saving for many patients, but not all tumors respond—and some that do, may eventually become resistant. Investigators at Houston Methodist have identified a possible explanation for this resistance, ...
9 hours ago
0
3
Blood test spots failing prostate cancer treatment within 6-12 weeks, study finds
A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than current tests, according to a U.K.-wide study led by UCL researchers. The study, published in Nature ...
12 hours ago
0
5
Long-term trial challenges assumptions about lymph node radiation therapy in breast cancer
Final results from a landmark EORTC randomized trial with more than 20 years of follow-up show that irradiation of the internal mammary and medial supraclavicular lymph nodes reduces breast cancer mortality but does not improve ...
9 hours ago
0
7
Automation cuts prostate cancer drug candidate production from 6 hours to 38 minutes
A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the University of Missouri, Cancer Targeted Technology (CTT) and Isotherapeutics Group (ITG) discovered ...
9 hours ago
0
2
Open-access tool decodes DNA change patterns in breast cancer
A study led by Dr. Jason Pitt, Principal Investigator at the Cancer Science Institute of Singapore (CSI Singapore), has identified eight new "signatures" of DNA patterns (gains and/or losses) in breast cancer. By analyzing ...
14 hours ago
0
4
FDA blocked melanoma drug as confusion reigned under Makary
The U.S. Food and Drug Administration's decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw that the drug had prolonged the lives of a third of ...
8 hours ago
0
3
Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb, and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma. In two ...
15 hours ago
0
2
ESTRO: Select breast cancer patients may be able to omit surgery following ablative radiation
A select group of patients with early-stage breast cancer were able to omit surgery with no tumor progression after three years, according to results of a Phase 2 trial of ablative radiation therapy and endocrine therapy ...
17 hours ago
0
4
Understanding treatment response in high-risk bladder cancer
A new study may pave the way toward more personalized treatments for patients with high-risk bladder cancer, according to a study published in European Urology.
20 hours ago
0
3
Weight-loss drugs tied to lower death, recurrence risk after breast cancer
New research published in JAMA Network Open suggests that there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.
May 17, 2026
0
20
AI tool for radiotherapy can support the global effort to eliminate cervical cancer
An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at University College London ...
May 17, 2026
0
5
Breast cancer that has begun to spread could be controlled for longer with targeted radiotherapy
Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer without their cancer getting worse, according to the results of a small randomized controlled trial ...
May 17, 2026
0
16
Just two radiotherapy sessions given over eight days can treat prostate cancer without any extra side effects
Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of radiotherapy, according to results presented at the Congress of the European Society for Radiotherapy ...
May 17, 2026
0
8
New AI tool could replace costly cancer gene expression profiling
A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes expressed in cancerous tumors. The AI-based tool, which they describe in the journal Cell, could ...
May 16, 2026
0
19
Overactive MYC helps tumors fix DNA breaks and resist chemotherapy, study finds
A protein best known for driving cancer growth also helps damaged tumor cells survive by repairing their DNA, according to a new study that could influence how some cancers are treated.
May 16, 2026
0
7
Meeting an AI doctor before a real-life consultation can improve cancer patients' understanding and reduce stress
Cancer patients who interact with an artificial intelligence (AI) avatar doctor before they meet their real-life consultant feel more knowledgeable and less stressed, according to research presented at the Congress of the ...
May 16, 2026
0
7
Blood test that detects tumor DNA could help guide treatment when cancer has spread
A blood test that detects tumor DNA circulating in the bloodstream may help select the most effective treatment options for cancer patients whose tumors have started to spread, according to one of the largest randomized controlled ...
May 16, 2026
0
5
Q&A: Examining the quality of life after esophageal and gastric cancer treatment
The survival rates of patients with esophageal and gastric cancers have improved. However, many survivors continue to experience long-term symptoms. On May 29, Kenneth Färnqvist will defend his thesis "The architecture of ...
May 16, 2026
0
4
When should you get a mammogram? Conflicting advice makes it hard to know
Deciding when to get routine mammograms is confusing. Some health groups recommend women begin at age 40 or 45 while another recently opted for age 50. They also differ on whether yearly or every other year is best.
May 16, 2026
0
2
Cancer risk awareness and concrete plans boosted gastric screening during COVID-19
A study conducted by researchers at University of Tsukuba revealed that individuals with higher cancer-related health literacy, perceived susceptibility to gastric cancer, and encouragement from family members or health care ...
May 16, 2026
0
3
New targeted radiopharmaceutical therapy induces remission in pancreatic cancer model
A newly developed targeted radiopharmaceutical treatment can effectively slow tumor growth in pancreatic ductal adenocarcinoma (PDAC), according to new research published in the May issue of The Journal of Nuclear Medicine. ...
May 15, 2026
0
79
Why breast cancer becomes more deadly with age
Researchers at Georgetown's Lombardi Comprehensive Cancer Center have identified a mechanism that may help explain a key reason why older people experience worse outcomes from breast cancer. The study implicates RAGE (Receptor ...
May 15, 2026
0
23
Study reveals promising new therapy for non-Hodgkin lymphoma
Not all cancers respond to the same treatments or have the same genetic origins. Epstein–Barr virus (EBV), a common and highly contagious virus, has been found to cause certain cancers, including non-Hodgkin lymphoma (NHL). ...
May 15, 2026
0
6
Experimental drug shows promise for some patients with advanced prostate cancer
For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are limited—and time matters. As the disease progresses, the window for effective, less intensive treatments begins ...
May 15, 2026
0
10
Novel CAR T cell therapy moves into clinical studies
The University of Texas MD Anderson Cancer Center and CTMC, a joint venture between UT MD Anderson and Resilience, today announced that the Food and Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational ...
May 15, 2026
0
6
